Epigenica has been awarded a Proof-of-Concept grant of €150,000 to begin commercialization of a new platform technology. The ERC PoC hmqPro will focus on developing novel highly-multiplexed, quantitative biomarker profiling.
Epigenica granted €150,000 from the ERC for a 2nd time
![](https://usercontent.one/wp/www.epigenica.se/wp-content/uploads/2022/02/erc.png?media=1718713973)